Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3674200

Cl.NCCCC[C@H](N)C(=O)NO

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
DPP4 known ✓ P27487 2/20 0.42
GSR P00390 1/20 0.57
GNAI3 P08754 1/20 0.53
GNAO1 P09471 1/20 0.53
GNAI1 P63096 1/20 0.53
DPP7 Q9UHL4 7/20 0.49
DPP8 Q6V1X1 3/20 0.49
DPP9 Q86TI2 3/20 0.49
MMP2 P08253 1/20 0.45
TLR2 O60603 2/20 0.43
TERT O14746 3/20 0.41
RNPEP Q9H4A4 1/20 0.41
LTA4H P09960 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18373043 0.98 GSR (0.59) GSRGNAI3GNAO1GNAI1DPP7
SCHEMBL11771047 0.98 GSR (0.59) GSRGNAI3GNAO1GNAI1DPP7
SCHEMBL198508 0.98 GSR (0.59) GSRGNAI3GNAO1GNAI1DPP7
SCHEMBL11221181 0.91 GSR (0.50) GSRGNAI3GNAO1GNAI1DPP7
SCHEMBL11221184 0.91 GSR (0.50) GSRGNAI3GNAO1GNAI1DPP7
SCHEMBL11221191 0.91 GSR (0.50) GSRGNAI3GNAO1GNAI1DPP7
SCHEMBL5499007 0.83 GSR (0.61) GSRGNAI3GNAO1GNAI1DPP7
SCHEMBL5667565 0.81 GSR (0.59) GSRGNAI3GNAO1GNAI1DPP7
SCHEMBL5495401 0.81 GSR (0.59) GSRGNAI3GNAO1GNAI1DPP7
SCHEMBL6315105 0.81 GSR (0.59) GSRGNAI3GNAO1GNAI1DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743558-A1 WASHING MACHINE AND METHOD Unilever IP Holdings B.V. (NL) 2026-05-20 EP disclosed
WO-2026099021-A1 METHOD FOR TREATING FABRICS UNILEVER IP HOLDINGS B.V. (NL) 2026-05-15 WO disclosed
WO-2026099020-A1 LIQUID LAUNDRY COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2026-05-15 WO disclosed
WO-2026099023-A1 LIQUID LAUNDRY COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2026-05-15 WO disclosed
WO-2026099027-A1 WASHING MACHINE AND WASHING METHOD UNILEVER IP HOLDINGS B.V. (NL) 2026-05-15 WO disclosed
WO-2026099024-A1 LIQUID LAUNDRY COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2026-05-15 WO disclosed
WO-2026099025-A1 LIQUID LAUNDRY COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2026-05-15 WO disclosed
WO-2026099022-A1 LIQUID LAUNDRY COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2026-05-15 WO disclosed
US-20260085256-A1 WASHING MACHINE AND WASHING METHOD CONOPCO, INC., D/B/A UNILEVER (US) 2026-03-26 US disclosed
US-20260085260-A1 WASHING MACHINE AND WASHING METHOD CONOPCO, INC., D/B/A UNILEVER (US) 2026-03-26 US disclosed
WO-2024056331-A1 WASHING MACHINE AND WASHING METHOD UNILEVER IP HOLDINGS B.V. (NL) 2024-03-21 WO disclosed
WO-2024056332-A1 WASHING MACHINE AND WASHING METHOD UNILEVER IP HOLDINGS B.V. (NL) 2024-03-21 WO disclosed
WO-2023227335-A1 LIQUID COMPOSITION COMPRISING LINEAR ALKYL BENZENE SULPHONATE, METHYL ESTER ETHOXYLATE AND ALKOXYLATED ZWITTERIONIC POLYAMINE POLYMER UNILEVER IP HOLDINGS B.V. (NL) 2023-11-30 WO disclosed
WO-2023227331-A1 COMPOSITION COMPRISING A SPECIFIC METHYL ESTER ETHOXYLATE SURFACTANT AND A LIPASE UNILEVER IP HOLDINGS B.V. (NL) 2023-11-30 WO disclosed
WO-2023227332-A1 LAUNDRY LIQUID COMPOSITION COMPRISING A SURFACTANT, AN ALKOXYLATED ZWITTERIONIC POLYAMINE POLYMER AND A PROTEASE UNILEVER IP HOLDINGS B.V. (NL) 2023-11-30 WO disclosed
WO-2023227421-A1 LAUNDRY LIQUID COMPOSITION COMPRISING A SURFACTANT, AN ALKOXYLATED ZWITTERIONIC POLYAMINE POLYMER, AND A FRAGRANCE UNILEVER IP HOLDINGS B.V. (NL) 2023-11-30 WO disclosed
WO-2023227375-A1 LAUNDRY LIQUID COMPOSITION COMPRISING A SURFACTANT, AN AMINOCARBOXYLATE, AN ORGANIC ACID AND A FRAGRANCE UNILEVER IP HOLDINGS B.V. (NL) 2023-11-30 WO disclosed
EP-2139461-A2 AMINO DERIVATIVES TO PREVENT NEPHROTOXICITY AND CANCER Recepticon Aps (DK) 2010-01-06 EP disclosed
WO-2008113364-A2 AMINO DERIVATIVES TO PREVENT NEPHROTOXICITY AND CANCER RECEPTICON APS (DK) 2008-09-25 WO disclosed
US-5192807-A Klebsiella culture, antimalaria, killing Plasmodium by iron chelation INSTITUT PASTEUR (FR) 1993-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085260-A1 WASHING MACHINE AND WASHING METHOD ACHE, TRIM25, SAMM50 DPP4 1895/4885GSR 2659/4885GNAI3 4856/4885
US-20260085256-A1 WASHING MACHINE AND WASHING METHOD ABHD11, ABHD12, ABHD16A DPP4 2937/4885GSR 3387/4885GNAI3 4854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.